← Open Payments lookup

MATTHEW SCHULKE: Open Payments

NPI 1861908576 · KYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,944 in 121 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $481 · 2025 $1,944

Food & beverage: $1,857Education: $87
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.47$668
Alkermes, Inc.21$281
Neurocrine BioSciences, Inc.17$271
Otsuka America Pharmaceutical, Inc.12$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$171
E.R. Squibb & Sons, L.L.C.6$170
Axsome Therapeutics, Inc.4$75
Janssen Pharmaceuticals, Inc2$42
Supernus Pharmaceuticals, Inc.2$42
ABBVIE INC.1$17

Products named: UZEDY, INGREZZA, ARISTADA, CAPLYTA, COBENFY, REXULTI, ABILIFY ASIMTUFII, Auvelity.

Industry payments across TX — which companies pay providers there.